Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glimepiride vs Sitagliptin as Add-on to Metformin in Severe Insulin Deficiency Diabetes
NCT05386186Phase 4Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Jan 2022
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of glimepiride in type 2 diabetes mellitus (T2DM), sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
glimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05386186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05386186.